Ultrase Oral Capsule, Gastro-Resistant Sprinkles 4500-20000-25000U Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Ultrase: Oral capsule, gastro-resistant sprinkles (4500-20000-25000U)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_1671.JPG
Ultrase Cap
Actavis- US Brands formerly Aptalis Pharma, a wholly owned subsidiary of Forest, Formerly Axcan Pharma US, Inc.
Pill Identification: ULTRASE 
Drug Image file DrugItem_7145.JPG
Pancrelipase 4,500unit DR Cap
Sun Pharmaceutical Industries, Inc.
Pill Identification: MUTUAL 688 MUTUAL 688 
Drug Image file DrugItem_5901.JPG
Pancrelipase 4,500unit DR Cap
United Research Laboratories, Inc. a subsidiary of Sun Pharmaceutical Industries, Inc.
Pill Identification: MUTUAL 688 MUTUAL 688 
Drug Image file DrugItem_1566.JPG
Pangestyme EC DR Cap
Ethex Corporation
Pill Identification: AquaPure EC 031,ETHEX 031 
Drug Image file DrugItem_8908.JPG
Pangestyme EC DR Cap
Ethex Corporation
Pill Identification: AquaPure EC 031,ETHEX 031 
Drug Image file DrugItem_2858.JPG
Lipram 4500 DR Cap
Global Pharmaceuticals
Pill Identification: 0115 7035 
Drug Image file DrugItem_9208.JPG
Pancrelipase 4,500unit DR Cap
Major Pharmaceuticals Inc
Pill Identification: B 406 
Drug Image file DrugItem_7440.JPG
Panocaps-4500 DR Cap
Breckenridge Inc
Pill Identification: B 406 
Drug Image file DrugItem_7049.JPG
Pancrease 4500 DR Cap
Janssen Pharmaceuticals, Inc, formerly Ortho-McNeil Pharmaceuticals
Pill Identification: Pancrease McNEIL 

In-Depth Information

Ultrase Capsule

NDC: 589140045
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)





Storage Information
Do not refrigerate
Store in a dry place
Store between 59 to 77 degrees F
Ultrase Capsule
Drug Image file DrugItem_1671.JPG
Actavis- US Brands formerly Aptalis Pharma, a wholly owned subsidiary of Forest, Formerly Axcan Pharma US, Inc.
Pill Identification: ULTRASE 
Shape: capsule
Color: white

Reported Side Effects for Ultrase Capsule

Skin Rash Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Rash With Pustules Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Breathing Difficulties Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Hives Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Itching Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Low Blood Sugar Incidence:
2.0%*
Severity: MODERATE
Onset: EARLY
Increased Blood Sugar Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Infection Incidence:
3.0-11.0%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
3.0-18.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
3.0-15.0%*
Severity: MILD
Onset: EARLY
Gas Incidence:
3.0-9.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
4.0-6.0%*
Severity: MILD
Onset: EARLY
Sore Throat Incidence:
4.0%*
Severity: MILD
Onset: DELAYED
Cough Incidence:
4.0-10.0%*
Severity: MILD
Onset: DELAYED
Vomiting Incidence:
6.0%*
Severity: MILD
Onset: EARLY
Nose Bleed Incidence:
7.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
10.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
10.0%*
Severity: MILD
Onset: EARLY
Enlarged Lymph Nodes Incidence:
11.0%*
Severity: MODERATE
Onset: DELAYED
Ear Pain Incidence:
11.0%*
Severity: MILD
Onset: EARLY
Stuffy Nose Incidence:
14.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Ultrase

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5